Drug Shortage Report for M-QUETIAPINE FUMARATE XR
Report ID | 233189 |
Drug Identification Number | 02527960 |
Brand name | M-QUETIAPINE FUMARATE XR |
Common or Proper name | M-QUETIAPINE |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-06-25 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-10-01 | French | Compare |
v5 | 2024-10-01 | English | Compare |
v4 | 2024-09-03 | French | Compare |
v3 | 2024-09-03 | English | Compare |
v2 | 2024-07-17 | French | Compare |
v1 | 2024-07-17 | English | Compare |
Showing 1 to 6 of 6